This includes a complex karyotype with the frequent involvement of the chromosome 17p (TP53) locus, as well the exclusion of most of the somatic genetic abnormalities representing other well-defined molecular AML subgroups [3]. The gene discussed is TP53; the disease is acute myeloid leukemia.